Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Hair follicle regeneration suppresses Ras-driven oncogenic growth.

Pineda CM, Gonzalez DG, Matte-Martone C, Boucher J, Lathrop E, Gallini S, Fons NR, Xin T, Tai K, Marsh E, Nguyen DX, Suozzi KC, Beronja S, Greco V.

J Cell Biol. 2019 Sep 5. pii: jcb.201907178. doi: 10.1083/jcb.201907178. [Epub ahead of print]

PMID:
31488583
2.

In vivo dynamics of T cells and their interactions with dendritic cells in mouse cutaneous graft-versus-host disease.

Morin-Zorman S, Wysocki C, Zhu J, Li H, Zorman S, Matte-Martone C, Kisanga E, McNiff J, Jain D, Gonzalez D, Rothstein DM, Lakkis FG, Haberman A, Shlomchik WD.

Blood Adv. 2019 Jul 23;3(14):2082-2092. doi: 10.1182/bloodadvances.2019000227.

3.

Correction of aberrant growth preserves tissue homeostasis.

Brown S, Pineda CM, Xin T, Boucher J, Suozzi KC, Park S, Matte-Martone C, Gonzalez DG, Rytlewski J, Beronja S, Greco V.

Nature. 2017 Aug 17;548(7667):334-337. doi: 10.1038/nature23304. Epub 2017 Aug 2.

4.

Differential requirements for myeloid leukemia IFN-γ conditioning determine graft-versus-leukemia resistance and sensitivity.

Matte-Martone C, Liu J, Zhou M, Chikina M, Green DR, Harty JT, Shlomchik WD.

J Clin Invest. 2017 Jun 30;127(7):2765-2776. doi: 10.1172/JCI85736. Epub 2017 Jun 12.

5.

Profound depletion of host conventional dendritic cells, plasmacytoid dendritic cells, and B cells does not prevent graft-versus-host disease induction.

Li H, Demetris AJ, McNiff J, Matte-Martone C, Tan HS, Rothstein DM, Lakkis FG, Shlomchik WD.

J Immunol. 2012 Apr 15;188(8):3804-11. doi: 10.4049/jimmunol.1102795. Epub 2012 Mar 14.

6.

Mechanisms of antigen presentation to T cells in murine graft-versus-host disease: cross-presentation and the appearance of cross-presentation.

Wang X, Li H, Matte-Martone C, Cui W, Li N, Tan HS, Roopenian D, Shlomchik WD.

Blood. 2011 Dec 8;118(24):6426-37. doi: 10.1182/blood-2011-06-358747. Epub 2011 Sep 30.

7.

Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution.

Li N, Matte-Martone C, Zheng H, Cui W, Venkatesan S, Tan HS, McNiff J, Demetris AJ, Roopenian D, Kaech S, Shlomchik WD.

Blood. 2011 Nov 24;118(22):5965-76. doi: 10.1182/blood-2011-07-367011. Epub 2011 Sep 13.

8.
9.

Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells.

Li H, Matte-Martone C, Tan HS, Venkatesan S, McNiff J, Demetris AJ, Jain D, Lakkis F, Rothstein D, Shlomchik WD.

J Immunol. 2011 Jan 1;186(1):230-41. doi: 10.4049/jimmunol.1002965. Epub 2010 Nov 22.

10.

Langerhans cells are not required for graft-versus-host disease.

Li H, Kaplan DH, Matte-Martone C, Tan HS, Venkatesan S, Johnson K, Demetris AJ, McNiff J, Shlomchik MJ, Shlomchik WD.

Blood. 2011 Jan 13;117(2):697-707. doi: 10.1182/blood-2010-07-299073. Epub 2010 Oct 13.

11.

Recipient B cells are not required for graft-versus-host disease induction.

Matte-Martone C, Wang X, Anderson B, Jain D, Demetris AJ, McNiff J, Shlomchik MJ, Shlomchik WD.

Biol Blood Marrow Transplant. 2010 Sep;16(9):1222-30. doi: 10.1016/j.bbmt.2010.03.015. Epub 2010 Mar 23.

12.

Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia.

Zheng H, Matte-Martone C, Jain D, McNiff J, Shlomchik WD.

J Immunol. 2009 May 15;182(10):5938-48. doi: 10.4049/jimmunol.0802212.

13.

MyD88-dependent, superoxide-initiated inflammation is necessary for flow-mediated inward remodeling of conduit arteries.

Tang PC, Qin L, Zielonka J, Zhou J, Matte-Martone C, Bergaya S, van Rooijen N, Shlomchik WD, Min W, Sessa WC, Pober JS, Tellides G.

J Exp Med. 2008 Dec 22;205(13):3159-71. doi: 10.1084/jem.20081298. Epub 2008 Dec 8.

14.

Characterization of a novel gain of function glucocorticoid receptor knock-in mouse.

Zhang J, Ge R, Matte-Martone C, Goodwin J, Shlomchik WD, Mamula MJ, Kooshkabadi A, Hardy MP, Geller D.

J Biol Chem. 2009 Mar 6;284(10):6249-59. doi: 10.1074/jbc.M807997200. Epub 2008 Nov 18.

15.

CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.

Matte-Martone C, Liu J, Jain D, McNiff J, Shlomchik WD.

Blood. 2008 Apr 1;111(7):3884-92. doi: 10.1182/blood-2007-11-125294. Epub 2008 Jan 25.

16.

Memory T cells in GVHD and GVL.

Anderson BE, Zheng H, Taylor PA, Matte-Martone C, McNiff JM, Jain D, Demetris AJ, Panoskaltsis-Mortari A, Ager A, Blazar BR, Shlomchik MJ, Shlomchik WD.

Biol Blood Marrow Transplant. 2008 Jan;14(1 Suppl 1):19-20. Review. No abstract available. Erratum in: Biol Blood Marrow Transplant. 2008 Nov;14(11):1317-8.

PMID:
19418622
17.

Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease.

Zheng H, Matte-Martone C, Li H, Anderson BE, Venketesan S, Sheng Tan H, Jain D, McNiff J, Shlomchik WD.

Blood. 2008 Feb 15;111(4):2476-84. Epub 2007 Nov 28.

Supplemental Content

Loading ...
Support Center